Please provide your email address to receive an email when new articles are posted on . Medicrea announced its UNiD IB3D patient-matched interbody cages were cleared by the FDA, reportedly making it ...
LYON, France & NEW YORK--(BUSINESS WIRE)--The Medicrea ® Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered device ...
LYON, France & NEW YORK--(BUSINESS WIRE)--The Medicrea ® Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered spinal ...
LYON, France & NEW YORK--(BUSINESS WIRE)-- MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through ...
MEDICREA, pioneering the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants with its UNiD ASI (Adaptive Spine Intelligence) proprietary ...
Medicrea scored an FDA OK for its 3D-printed titanium interbody devices for spine surgery. The IB3D suite of devices features the company’s surgeon-adaptive technology, dubbed AdapTEK, which allows ...
The second day of trade talks between the U.S. and China was paving the way for a "productive meeting" between President Donald Trump and President Xi Jinping, Washington's top trade envoy said in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results